triazoles has been researched along with Rhabdomyosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bagella, L; Bordoni, V; Fais, M; Fiorentino, FP; Marchesi, I; Sanna, L; Zoroddu, S | 1 |
| Boedicker, C; Enßle, JC; Fulda, S; Knapp, S; Vogler, M; Wanior, M | 1 |
| Dubois, L; Eriksson, J; Lambin, P; Lieuwes, NG; Peeters, SG; van Dongen, GA; van Elmpt, W; Zegers, CM | 1 |
3 other study(ies) available for triazoles and Rhabdomyosarcoma
| Article | Year |
|---|---|
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment.
Topics: Apoptosis; Azepines; Cell Line, Tumor; Cell Proliferation; Child; Humans; Proto-Oncogene Proteins c-myc; Rhabdomyosarcoma; Transcription Factors; Triazoles | 2022 |
Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azepines; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Proteins; Rhabdomyosarcoma; Triazoles | 2018 |
A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Computer Simulation; Imidazoles; Misonidazole; Models, Biological; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Triazoles | 2015 |